[1]
K. B. Siregar, T. W. Manuaba, M. N. Dahlan Lubis, and R. J. Sembiring, “CASPASE 3 AS PROGNOSTIC MARKER FOR TRIPLE NEGATIVE BREAST CANCER CHEMOTHERAPY”, Asian J Pharm Clin Res, vol. 10, no. 11, pp. 304–307, Nov. 2017.